Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes. | Int J Mol Sci | 2023 | 36902139 | PubTator, text mining | PubMed |
| Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax. | Cancer Discov | 2023 | 36892565 | PubTator, text mining | PubMed |
| Beyond apoptosis: evidence of other regulated cell death pathways in the ovary throughout development and life. | Hum Reprod Update | 2023 | 36857094 | PubTator, text mining | PubMed |
| Gender, Racial, and Ethnic and Inequities in Receipt of Multiple National Institutes of Health Research Project Grants. | JAMA Netw Open | 2023 | 36853608 | PubTator, text mining | PubMed |
| Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells. | Discov Oncol | 2023 | 36853387 | PubTator, text mining | PubMed |
| Structure and function of African swine fever virus proteins: Current understanding. | Front Microbiol | 2023 | 36846791 | PubTator, text mining | PubMed |
| Mitochondrial gene expression signature predicts prognosis of pediatric acute myeloid leukemia patients. | Front Oncol | 2023 | 36845715 | PubTator, text mining | PubMed |
| Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs. | Molecules | 2023 | 36838947 | PubTator, text mining | PubMed |
| Cannabinoid Mixture Affects the Fate and Functions of B Cells through the Modulation of the Caspase and MAP Kinase Pathways. | Cells | 2023 | 36831255 | PubTator, text mining | PubMed |
| PIWIL2 Regulates the Proliferation, Apoptosis and Colony Formation of Colorectal Cancer Cell Line. | Iran J Biotechnol | 2023 | 36811102 | PubTator, text mining | PubMed |
| Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene. | Exp Hematol Oncol | 2023 | 36797781 | PubTator, text mining | PubMed |
| Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation. | Cell Rep Med | 2023 | 36787738 | PubTator, text mining | PubMed |
| Physician-Specific Symptoms of Burnout Compared to a Non-Physicians Group. | Int J Environ Res Public Health | 2023 | 36768057 | PubTator, text mining | PubMed |
| BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. | Blood Adv | 2023 | 36763538 | PubTator, text mining | PubMed |
| National Institutes of Health research project grant inflation 1998 to 2021. | Elife | 2023 | 36762661 | PubTator, text mining | PubMed |
| Demographic composition of National Institutes of Health Clinical and Translational Science Awards (CTSA) Program principal investigators, scholars, and trainees. | J Clin Transl Sci | 2023 | 36755537 | PubTator, text mining | PubMed |
| Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells. | Sci Rep | 2023 | 36720985 | PubTator, text mining | PubMed |
| Computational approaches for the design of modulators targeting protein-protein interactions. | Expert Opin Drug Discov | 2023 | 36715303 | PubTator, text mining | PubMed |
| Phylogenetic analysis of the MCL1 BH3 binding groove and rBH3 sequence motifs in the p53 and INK4 protein families. | PLoS One | 2023 | 36696417 | PubTator, text mining | PubMed |
| Rational design of Harakiri (HRK)-derived constrained peptides as BCL-xL inhibitors. | Chem Commun (Camb) | 2023 | 36692261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers?page=9